First humans receive experimental drug in early safety test
NCT ID NCT06782477
Summary
This is the first study testing a new drug called STAR-0310 in humans. Researchers are giving single doses to 40 healthy adults to check for side effects and see how the body processes the medication. The study will help determine if STAR-0310 is safe enough for future testing in people with medical conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Austin Clinical Research Unit - Early Clinical Development
Austin, Texas, 78744, United States
Conditions
Explore the condition pages connected to this study.